HIND Vyome Holdings, Inc.
$1.72▲ +1.18%
Healthcare
Other
After hours
$1.74▲ +1.16%
Oct 28, 4:13 PM ET
Volume 8.0K
Avg Volume (10D) 8.6K
Key Metrics & Fundamentals
Market Cap
$12.07M
P/E Ratio
1.0
Div Yield
0.00%
52W Range
1.62 - 6.56
% vs 50 MA
-14.96%
% vs 200 MA
-23.82%
RSI-14
30.0
MACD Histogram
-0.0200
Beta (1Y vs SPY)
1.14
Free Cash Flow
-$903,712
Gross Rev
$26,955
Gross Profit
$11,658
EBITDA
-$713,748
COGS
$15,297
Operating Exp
$874,224
Operating Income
-$862,566
EBIT
-$862,566
Pretax Income
-$719,683
Net Income
-$685,556
EPS (Diluted)
-0.10
Price & Volume History
Loading chart…
Recent News
Vyome Co-Founder Dr. Shiladitya Sengupta Promoted to Professor at Harvard Medical School
Business Wire · Oct 26, 2026 8:00 AM ET
Vyome Receives USPTO Notice of Allowance for U.S. Patent Covering VT-1908, its Novel Topical Mycophenolate Program Targeting the $20+ Billion Ocular Inflammation Market
Business Wire · Oct 5, 2026 8:00 AM ET
Vyome Appoints Experienced Public Company Finance Executive Jerry Leonard as Chief Financial Officer
Business Wire · Sep 14, 2026 8:00 AM ET
Vyome Holdings Reports Second Quarter 2026 Results Highlighted by Advancement of Lead VT-1953 Program, Pipeline Expansion and Strong Balance Sheet
Business Wire · Aug 25, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See HIND's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.